KOKH kliinilised uuringud osariigis Oklahoma
8 uuringut haiguse KOKH jaoks otsivad osalejaid osariigis Oklahoma.
Linnad osariigis Oklahoma
Ametlik uuringutekst (inglise keeles)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Norman
- Research Site, Oklahoma City
- Research Site, Tulsa
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Layrek Clinical Research- Site Number : 8400066, Tulsa
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 1. okt 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Oklahoma City
- Research Site, Tulsa
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Oklahoma City
- Research Site, Tulsa
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Oklahoma City
VärbamineFaas 3
Vanused 40–80 · Kõik sood · Uuendatud 3. sept 2026 · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Edmond
VärbamineFaas 3
Vanused 40–75 · Kõik sood · Uuendatud 28. juuli 2026 · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hightower Clinical, Oklahoma City
VärbamineVaatlusuuring
Vanused 50 ja vanemad · Kõik sood · Uuendatud 5. aug 2025 · NCT06122077Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.